Wingate at Needham Campus
About the Wingate at Needham Campus
Wingate at Needham is a senior living community, offering continuum of care options for residents consisting of the Wingate Residences and the Wingate at Needham skilled care center.
The Wingate Residences is the premier senior living community in Needham, providing independent living, assisted living and memory care services. Life at the Wingate Residences is interactive – the building is designed to inspire engagement and programming is created to foster inclusion. Voted the best in Needham and the region by residents and families, the Wingate Residences proudly delivers the warmth of home and the hospitality of a 5-star hotel, while providing exceptional services and ensuring the safety and security of its residents.
Wingate at Needham’s 142-bed skilled care center delivers exceptional short-term rehab, post-acute and long-term care. Serving the community for over 20 years, the skilled care center completes the life-care community at the Wingate at Needham Campus with an accessible option for all residents as their care needs evolve.
About Wingate Healthcare
Wingate Healthcare is the Northeast’s premiere provider of healthcare and hospitality for seniors. Owned and operated by the Schuster family for over 25 years, Wingate Healthcare delivers exceptional short-term rehab, post-acute care and long-term care in skilled nursing centers and assisted and independent living communities throughout Massachusetts and New York. With select centers offering special programs in Memory and Dementia Care, Ventilator Care, Pulmonary Rehabilitation and more, Wingate Healthcare is dedicated to meeting the critical needs and enhancing the lives of residents and families. Wingate Healthcare takes great pride in providing warm and welcoming communities and shares principles of respect, loyalty and trust. For more information, visit www.wingatehealthcare.com.
About the HOPE Study
The Health Outreach Program for the Elderly (HOPE) study is the flagship research project of the Boston University Alzheimer’s Disease and CTE Center (BU ADC). The BU ADC is funded by the National Institutes of Health and is one of only 27 similar centers across the country, all working together to improve our understanding of Alzheimer’s disease (AD) so that one day we will live in a world without this devastating disease.
The HOPE study is a longitudinal research investigation of several hundred participants from all around Greater Boston and New England. The group of participants includes some people who are cognitively healthy, some who have early symptoms of AD (sometimes referred to as Mild Cognitive Impairment), and some who have the dementia caused by AD. HOPE participants are evaluated annually for a half-day examination consisting of physical and neurological examinations, formal tests of memory and other cognitive skills, and a blood draw for genetic and other measurements. Some participants have been involved in the HOPE study for almost 20 years. However, new participants are enrolled on an ongoing basis.
In addition to providing the researchers with valuable information to answer important scientific questions, HOPE participants are also routinely asked if they would like to volunteer for other research studies, including: state-of-the-art investigations of new methods to diagnose AD accurately and early (even before symptoms begin), clinical trials of new medications to treat and prevent AD symptoms; studies of genetic and other risk factors; projects to examine the effect of exercise on memory; projects aimed at understanding the impact of dementia on family and other caregivers; and several studies on the long-term consequences of repetitive head impacts, such as those experienced by football players and other athletes. For more information, visit www.bu.edu/alzresearch.